JP4870907B2 - 深部静脈血栓症患者の静脈血栓症の治療および／または二次的予防のためのイドラパリナックス（ｓａｎｏｒｇ３４００６） - Google Patents
深部静脈血栓症患者の静脈血栓症の治療および／または二次的予防のためのイドラパリナックス（ｓａｎｏｒｇ３４００６） Download PDFInfo
- Publication number
- JP4870907B2 JP4870907B2 JP2003563570A JP2003563570A JP4870907B2 JP 4870907 B2 JP4870907 B2 JP 4870907B2 JP 2003563570 A JP2003563570 A JP 2003563570A JP 2003563570 A JP2003563570 A JP 2003563570A JP 4870907 B2 JP4870907 B2 JP 4870907B2
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- sanorg
- patients
- dose
- thrombosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP002075374.5 | 2002-01-29 | ||
| EP02075374 | 2002-01-29 | ||
| PCT/EP2003/000696 WO2003063881A1 (en) | 2002-01-29 | 2003-01-23 | Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005519919A JP2005519919A (ja) | 2005-07-07 |
| JP2005519919A5 JP2005519919A5 (enExample) | 2006-03-16 |
| JP4870907B2 true JP4870907B2 (ja) | 2012-02-08 |
Family
ID=27635850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003563570A Expired - Fee Related JP4870907B2 (ja) | 2002-01-29 | 2003-01-23 | 深部静脈血栓症患者の静脈血栓症の治療および／または二次的予防のためのイドラパリナックス（ｓａｎｏｒｇ３４００６） |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7709463B2 (enExample) |
| EP (1) | EP1471924B1 (enExample) |
| JP (1) | JP4870907B2 (enExample) |
| CN (1) | CN1622813A (enExample) |
| AR (1) | AR038320A1 (enExample) |
| AT (1) | ATE323497T1 (enExample) |
| AU (1) | AU2003205664B2 (enExample) |
| BR (1) | BR0307196A (enExample) |
| CA (1) | CA2472957C (enExample) |
| CY (1) | CY1107661T1 (enExample) |
| DE (1) | DE60304678T2 (enExample) |
| DK (1) | DK1471924T3 (enExample) |
| EA (1) | EA007204B1 (enExample) |
| ES (1) | ES2262971T3 (enExample) |
| MX (1) | MXPA04007310A (enExample) |
| NO (1) | NO332699B1 (enExample) |
| PE (1) | PE20030855A1 (enExample) |
| PL (1) | PL207144B1 (enExample) |
| PT (1) | PT1471924E (enExample) |
| SI (1) | SI1471924T1 (enExample) |
| TW (1) | TWI281861B (enExample) |
| WO (1) | WO2003063881A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008521903A (ja) * | 2004-12-01 | 2008-06-26 | オーエスアイ・ファーマスーティカルズ・インコーポレーテッド | Ｎ置換されたベンズイミダゾリルＣ−ｋｉｔ阻害剤及びコンビナトリアルベンゾイミダゾールライブラリー |
| US9642822B2 (en) | 2011-05-27 | 2017-05-09 | Children's Medical Center Corporation | Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
| BR112022000255A8 (pt) | 2019-07-09 | 2022-03-22 | Optimvia Llc | Métodos para sintetizar polissacarídeos anticoagulantes |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378829A (en) * | 1990-04-23 | 1995-01-03 | Akzo N.V. | Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type |
-
2003
- 2003-01-14 TW TW092100703A patent/TWI281861B/zh not_active IP Right Cessation
- 2003-01-23 ES ES03702514T patent/ES2262971T3/es not_active Expired - Lifetime
- 2003-01-23 AT AT03702514T patent/ATE323497T1/de active
- 2003-01-23 MX MXPA04007310A patent/MXPA04007310A/es active IP Right Grant
- 2003-01-23 WO PCT/EP2003/000696 patent/WO2003063881A1/en not_active Ceased
- 2003-01-23 EA EA200400817A patent/EA007204B1/ru not_active IP Right Cessation
- 2003-01-23 BR BR0307196-0A patent/BR0307196A/pt not_active Application Discontinuation
- 2003-01-23 DE DE60304678T patent/DE60304678T2/de not_active Expired - Lifetime
- 2003-01-23 JP JP2003563570A patent/JP4870907B2/ja not_active Expired - Fee Related
- 2003-01-23 DK DK03702514T patent/DK1471924T3/da active
- 2003-01-23 CN CNA038028123A patent/CN1622813A/zh active Pending
- 2003-01-23 PE PE2003000071A patent/PE20030855A1/es not_active Application Discontinuation
- 2003-01-23 SI SI200330334T patent/SI1471924T1/sl unknown
- 2003-01-23 PL PL370557A patent/PL207144B1/pl unknown
- 2003-01-23 CA CA2472957A patent/CA2472957C/en not_active Expired - Fee Related
- 2003-01-23 EP EP03702514A patent/EP1471924B1/en not_active Expired - Lifetime
- 2003-01-23 PT PT03702514T patent/PT1471924E/pt unknown
- 2003-01-23 AU AU2003205664A patent/AU2003205664B2/en not_active Ceased
- 2003-01-23 US US10/502,706 patent/US7709463B2/en not_active Expired - Fee Related
- 2003-01-28 AR ARP030100237A patent/AR038320A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 NO NO20043195A patent/NO332699B1/no not_active IP Right Cessation
-
2006
- 2006-07-19 CY CY20061101002T patent/CY1107661T1/el unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378829A (en) * | 1990-04-23 | 1995-01-03 | Akzo N.V. | Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type |
Also Published As
| Publication number | Publication date |
|---|---|
| NO20043195L (no) | 2004-10-29 |
| US20050209175A1 (en) | 2005-09-22 |
| EA200400817A1 (ru) | 2005-02-24 |
| EA007204B1 (ru) | 2006-08-25 |
| PT1471924E (pt) | 2006-09-29 |
| TWI281861B (en) | 2007-06-01 |
| CA2472957A1 (en) | 2003-08-07 |
| CY1107661T1 (el) | 2013-04-18 |
| MXPA04007310A (es) | 2004-10-29 |
| EP1471924A1 (en) | 2004-11-03 |
| DE60304678D1 (de) | 2006-05-24 |
| PL370557A1 (en) | 2005-05-30 |
| ATE323497T1 (de) | 2006-05-15 |
| CA2472957C (en) | 2011-09-13 |
| HK1072361A1 (en) | 2005-08-26 |
| WO2003063881A1 (en) | 2003-08-07 |
| US7709463B2 (en) | 2010-05-04 |
| BR0307196A (pt) | 2004-11-03 |
| AR038320A1 (es) | 2005-01-12 |
| ES2262971T3 (es) | 2006-12-01 |
| PL207144B1 (pl) | 2010-11-30 |
| AU2003205664B2 (en) | 2008-06-05 |
| SI1471924T1 (sl) | 2006-10-31 |
| PE20030855A1 (es) | 2003-10-11 |
| DE60304678T2 (de) | 2007-04-05 |
| EP1471924B1 (en) | 2006-04-19 |
| CN1622813A (zh) | 2005-06-01 |
| DK1471924T3 (da) | 2006-08-21 |
| NO332699B1 (no) | 2012-12-10 |
| JP2005519919A (ja) | 2005-07-07 |
| TW200302104A (en) | 2003-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lindmarker et al. | Comparison of once-daily subcutaneous Fragmin® with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis | |
| KR101074430B1 (ko) | 항암 용도를 위한 독소루비신 제형 | |
| Borstad et al. | Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery | |
| JP2010053144A (ja) | 血管形成的に有効なｆｇｆ−２の単位用量および使用方法 | |
| US20120291789A1 (en) | Medical composition for protuberance of epithelium | |
| O'Keefe Jr et al. | Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction | |
| JP4870907B2 (ja) | 深部静脈血栓症患者の静脈血栓症の治療および／または二次的予防のためのイドラパリナックス（ｓａｎｏｒｇ３４００６） | |
| Buchanan et al. | Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: importance of heparin cofactor II | |
| Ali et al. | Acute pseudogout following intra-articular injection of high molecular weight hyaluronic acid | |
| Hanson et al. | Studies of suloctidil in experimental thrombosis in baboons | |
| AU2003205664A1 (en) | Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis | |
| CN111494366A (zh) | 二甲基氨基含笑内酯在制备抗衰老药物上的应用 | |
| US20100048455A1 (en) | Formulations For Therapeutic Administration Of Thyroid Stimulating Hormone (TSH) | |
| Ross et al. | Solvent systems for intracarotid 1, 3-bis (2-chloroethyl)-1-nitrosourea (BCNU) infusion | |
| Lopez et al. | Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer | |
| HK1072361B (en) | Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis | |
| UA127661C2 (uk) | Композиції дантролену та способи їх застосування | |
| CN1602197A (zh) | 特定剂量的Fondaparinux Sodi um在治疗急性冠状动脉综合征中的应用 | |
| CARROLL et al. | Hypophosphatemia and Reye's syndrome | |
| JP2001354572A (ja) | 肝疾患処置剤 | |
| de Rick et al. | Clinical pharmacokinetic studies of digoxin and digitoxin in the dog | |
| Lockner et al. | Clinical Trial of a New Intramuscular Iron Preparation in Iron Deficiency Anaemia | |
| Prandoni | Current status of the clinical use of heparin fractions | |
| Krupinski et al. | in the Management of Thrombotic Disorders | |
| Gadalla et al. | Pharmacokinetics of Lignocaine in Humans After Peri-Oral Injections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060123 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060124 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091006 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091228 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100108 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100202 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110301 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110701 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110714 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111101 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111118 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141125 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |